Kanchan Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 27-06-2024
- Paid Up Capital ₹ 8.10 M
as on 27-06-2024
- Company Age 34 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 119.31 Cr
as on 27-06-2024
- Satisfied Charges ₹ 52.35 Cr
as on 27-06-2024
- Revenue 0.34%
(FY 2021)
- Profit 108.69%
(FY 2021)
- Ebitda 6.94%
(FY 2021)
- Net Worth 23.70%
(FY 2021)
- Total Assets 9.79%
(FY 2021)
About Kanchan Pharma
The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.10 M.
The company currently has active open charges totaling ₹119.31 Cr. The company has closed loans amounting to ₹52.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhikhalal Shah, Mona Shah, Rakesh Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232GJ1990PTC014539
- Company No.
014539
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kanchan Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rushika Shah  | Director | 16-Apr-2018 | Current |
| Bhikhalal Shah | Director | 25-Oct-1990 | Current |
| Mona Shah | Director | 16-Oct-1990 | Current |
| Rakesh Shah | Director | 16-Oct-1990 | Current |
Financial Performance and Corporate Structure Insights of Kanchan Pharma.
Kanchan Pharma Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 0.34% increase. The company also saw a substantial improvement in profitability, with a 108.69% increase in profit. The company's net worth Soared by an impressive increase of 23.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kanchan Pharma?
In 2021, Kanchan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rushika Capital Private LimitedActive 4 years 11 months
Rakesh Shah and Rushika Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Aug 2022 | ₹1.27 Cr | Open |
Hdfc Bank Limited Creation Date: 06 Jan 2021 | ₹8.00 Cr | Open |
Hdfc Bank Limited Creation Date: 04 Nov 2019 | ₹50.00 Cr | Open |
How Many Employees Work at Kanchan Pharma?
Kanchan Pharma has a workforce of 347 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kanchan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanchan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
